We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Cell-by date

22 March 2010 By Robert Cyran

Companies in the sector often resist liquidation, even if it s the wisest outcome. One small firm is adapting a biological process apoptosis, or preprogrammed death. Unhappy shareholders can withdraw their cash quota if things go wrong. It s a minor scientific breakthrough.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)